Toxoplasmosis is one of those Step 1 “if you see this, you must think that” diagnoses—especially in an HIV patient with focal neurologic deficits. It sits at the intersection of neuroinfectious disease, immunology, and radiology, and it’s extremely testable because the presentation, MRI findings, and empiric treatment algorithm are so patterned.
Big Picture: What Is Toxoplasmosis in HIV?
Toxoplasmosis is an infection caused by the protozoan Toxoplasma gondii. In the USMLE context, the key scenario is reactivation of latent infection in an immunocompromised host—most classically advanced HIV/AIDS.
High-yield one-liner
AIDS patient (often CD4 < 100) + fever + headache + focal deficits or seizures + multiple ring-enhancing brain lesions = cerebral toxoplasmosis (until proven otherwise).
First Aid Cross-References (where this shows up)
You’ll typically find toxoplasmosis in:
- Microbiology (Protozoa): Toxoplasma gondii (cat feces, undercooked meat; congenital triad)
- Neurology/Neuroimaging: ring-enhancing lesions; focal deficits; seizures
- Immunology/Infectious Disease (HIV opportunistic infections): CD4 thresholds, prophylaxis, empiric therapy vs biopsy
- Pathology: abscess-like necrotizing lesions
(Exact page numbers vary by edition, but these are the reliable FA “homes.”)
Epidemiology & Transmission (Step-Relevant)
How people get exposed (initial infection)
- Undercooked meat (tissue cysts)
- Cat feces (oocysts; litter box exposure)
What matters most for HIV
- In AIDS, disease is usually reactivation of latent tissue cysts rather than primary infection.
Pathophysiology: Why It Loves the Brain in AIDS
Core mechanism
- After initial exposure, tissue cysts persist (latent infection), including in brain and muscle.
- With impaired cell-mediated immunity (especially low CD4), cysts reactivate → necrotizing encephalitis and brain abscess–like lesions.
What your immune system normally uses
- Th1 response and IFN-γ activation of macrophages are central in controlling intracellular pathogens like Toxo.
- In HIV, loss of CD4 help → poor Th1 signaling → uncontrolled replication.
Pathology buzzwords (worth memorizing)
- Necrotizing abscesses (often multiple)
- Predilection for basal ganglia and corticomedullary junction (classic teaching, commonly tested)
Clinical Presentation: How It Shows Up on Exams
Typical symptoms
- Headache
- Fever
- Confusion/altered mental status
- Seizures
- Focal neurologic deficits
(e.g., unilateral weakness, aphasia, visual field defects)
Timing clue
- Often subacute over days to weeks.
High-yield association: CD4 count
- Most common when CD4 < 100 cells/µL (often < 50–100)
Imaging: The “Ring-Enhancing Lesions” Differential
Classic MRI/CT finding
- Multiple ring-enhancing lesions with surrounding edema (mass effect can occur)
Why ring enhancement?
- Central necrosis with peripheral inflammation/vascular permeability.
Step trap: toxoplasmosis vs primary CNS lymphoma
Both are common in AIDS and can present similarly. Use pattern recognition:
| Feature | Toxoplasmosis | Primary CNS lymphoma (PCNSL) |
|---|---|---|
| Number of lesions | Multiple (classic) | Often single (can be multiple) |
| Location | Basal ganglia, corticomedullary junction (classic) | Periventricular/common deep white matter |
| Enhancement | Ring-enhancing | Can be ring-enhancing in AIDS; classically homogeneous in immunocompetent |
| Serology | Often Toxo IgG+ (prior exposure) | EBV association |
| Next step | Empiric anti-toxo therapy | Consider biopsy if no response |
| Key association | Reactivation at CD4 < 100 | EBV, very low CD4 (often < 50) |
Clinical algorithm (very testable):
If AIDS + ring-enhancing brain lesions → treat empirically for toxoplasmosis first. If no improvement (often assessed clinically and/or radiographically after ~1–2 weeks), then consider brain biopsy to evaluate for PCNSL or other etiologies.
Diagnosis: How You Confirm (Without Over-testing)
Practical diagnostic approach (USMLE-style)
- Clinical context: HIV/AIDS with neuro symptoms
- Imaging: multiple ring-enhancing lesions
- Serology: Toxo IgG supports reactivation (IgM is less helpful here)
- Therapeutic trial: improvement on therapy supports diagnosis
Definitive diagnosis (less common on Step stems, but fair game)
- Brain biopsy showing tachyzoites/bradyzoite cysts (usually reserved for unclear cases or non-response)
Common distractors to keep in mind
- TB (tuberculomas) can also cause ring-enhancing lesions.
- Neurocysticercosis (especially in immigrants; seizures; calcifications).
- Bacterial abscess (often single; strong systemic infection clues).
- Progressive multifocal leukoencephalopathy (PML): non-enhancing demyelinating lesions (JC virus), usually no mass effect.
Treatment: What to Give (and Why)
First-line therapy (classic USMLE regimen)
- Pyrimethamine + sulfadiazine + leucovorin (folinic acid)
Why leucovorin?
Pyrimethamine inhibits dihydrofolate reductase → bone marrow suppression risk. Leucovorin rescue reduces hematologic toxicity.
Alternative regimens (if sulfa allergy or intolerance)
- Pyrimethamine + clindamycin + leucovorin
(High-yield alternative)
Adjuncts
- Corticosteroids: only if significant mass effect/edema causing increased ICP (not routine)
- Anticonvulsants: if seizures occur (not always prophylactic unless seizures)
Prophylaxis: Preventing Reactivation in HIV
When to start prophylaxis (high yield)
- CD4 < 100 cells/µL AND Toxo IgG positive (prior exposure)
What to use
- TMP-SMX (also provides Pneumocystis jirovecii pneumonia prophylaxis)
When to stop prophylaxis
- After immune reconstitution on ART (classically when CD4 rises above the threshold for a sustained period—your exam may phrase this as “CD4 > 200 for ≥3 months” in general OI prophylaxis logic, though specific guideline thresholds can vary; follow what the question stem implies).
Step 1 “Most Testable” High-Yield Facts (Rapid Review)
Must-know associations
- AIDS + multiple ring-enhancing brain lesions → toxoplasmosis
- CD4 < 100 is the key threshold
- Empiric treatment first, biopsy if no improvement
- Tx: pyrimethamine + sulfadiazine + leucovorin
- Prophylaxis: TMP-SMX if CD4 < 100 and IgG+
Classic exposure history (nice-to-have clues)
- Cat feces exposure
- Undercooked meat
Common question formats
- “HIV patient with seizures and ring-enhancing lesions—next best step?”
- “Which drug must be co-administered to prevent toxicity?”
- “Which OI prophylaxis is indicated at this CD4 count?”
- “Differentiate toxoplasmosis from primary CNS lymphoma”
Quick Clinical Reasoning Framework (What to Think on Test Day)
- Recognize: immunocompromised + focal neuro signs ± seizures
- Localize: brain parenchyma lesions with edema → mass effect possible
- Image: multiple ring-enhancing lesions → toxo high on list
- Act: start empiric anti-toxo therapy
- Reassess: no response → consider PCNSL and biopsy
Mini Table: Toxo vs PML vs Cryptococcal (Neuro OIs in HIV)
| Condition | CD4 (classic) | Key presentation | Imaging | Diagnostic clue |
|---|---|---|---|---|
| Toxoplasmosis | < 100 | Fever, headache, focal deficits, seizures | Multiple ring-enhancing lesions | Toxo IgG+, responds to therapy |
| PML (JC virus) | < 200 (often < 100) | Progressive focal deficits, usually afebrile | Non-enhancing white matter lesions, no mass effect | JC virus in CSF (PCR) |
| Cryptococcal meningitis | < 100 | Headache, fever, meningitis signs; ↑ICP | Often normal or nonspecific | India ink/CrAg, high opening pressure |
Takeaway
For Step 1, cerebral toxoplasmosis is a pattern: AIDS + CD4 < 100 + focal neuro deficits/seizures + multiple ring-enhancing lesions. Know the empiric treatment approach, the drug combo with leucovorin, and how to separate it from primary CNS lymphoma when the vignette tries to bait you.